These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treating essential hypertension. The first choice is usually a thiazide diuretic. Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125 [TBL] [Abstract][Full Text] [Related]
3. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
4. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]
5. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
6. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664 [TBL] [Abstract][Full Text] [Related]
7. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Thomas GN; Chan P; Tomlinson B Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy in diabetic patients. Weidmann P; Boehlen LM; de Courten M; Ferrari P J Hum Hypertens; 1992 Dec; 6 Suppl 2():S23-36. PubMed ID: 1289510 [TBL] [Abstract][Full Text] [Related]
11. The case for beta-blockers as first-line antihypertensive therapy. Cruickshank JM J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111 [TBL] [Abstract][Full Text] [Related]
13. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
14. Is cardioprotection important in the treatment of hypertension? Considerations for the ideal agent. Sleight P J Hypertens Suppl; 1993 Jun; 11(4):S49-53. PubMed ID: 8377034 [TBL] [Abstract][Full Text] [Related]
15. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325 [TBL] [Abstract][Full Text] [Related]
16. Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients. Plouin PF J Hum Hypertens; 1989 Dec; 3 Suppl 2():49-53; discussion 53-4. PubMed ID: 2575176 [TBL] [Abstract][Full Text] [Related]
17. Hyperlipidemia of diuretic therapy. Ames R Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566 [TBL] [Abstract][Full Text] [Related]
18. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
19. [Antihypertensive therapy in the nineties]. Weidmann P; Ferrari P Schweiz Rundsch Med Prax; 1992 Feb; 81(7):188-98. PubMed ID: 1535954 [TBL] [Abstract][Full Text] [Related]
20. Hypertension strategies for therapeutic intervention and prevention of end-organ damage. Houston MC Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]